Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-16-018907
Filing Date
2016-11-23
Accepted
2016-11-23 10:53:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 INFORMATION TO BE INCLUDED IN STATEMENTS FILED sc13g1116sunuh_relmadathera.htm SC 13G 29946
  Complete submission text file 0001213900-16-018907.txt   31306
Mailing Address 275 MADISON AVENUE, SUITE 702 NEW YORK NY 10016
Business Address 275 MADISON AVENUE, SUITE 702 NEW YORK NY 10016 646-677-3853
RELMADA THERAPEUTICS, INC. (Subject) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-88207 | Film No.: 162015326
SIC: 2834 Pharmaceutical Preparations

Mailing Address 810-1001 ANSAN PURGIO APT. WONGOK-DONG, DANWON-KU ANSAN-SI, KYUNGGI-DO M5 15373
Business Address
Uh Eun Sun (Filed by) CIK: 0001690200 (see all company filings)

Type: SC 13G